Parsemus Foundation: Difference between revisions
Content deleted Content added
Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0 |
Ii's called Vasalgel. |
||
| (18 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|American organization}} |
|||
{{notability|date=April 2013}} |
{{notability|Organizations|date=April 2013}} |
||
The '''Parsemus Foundation''' is an |
The '''Parsemus Foundation''' is an American [[non-governmental organization]] whose objective is to advance low-cost [[evidence-based medicine]]s not pursued by the [[pharmaceutical industry]].<ref name='ORiordanin 2011-07-15'>{{cite news |last=O'Riordan |first=Michael |url=http://www.medscape.com/viewarticle/746456 |title=What Is the Parsemus Foundation? |work=Heartwire |publisher=[[Medscape]] |date=2011-07-15 |accessdate=2017-03-21 }}</ref> The foundation's focus is on supporting small [[proof-of-concept]] studies and then pursuing press coverage of the results, so that the advances change treatment practice rather than disappearing into the scientific literature. Many of the studies supported involve low-cost approaches that are not under [[patent]]. |
||
==Background== |
==Background== |
||
Founded in 2005, Parsemus is an advocate of research into the plausibility of [[Reversible inhibition of sperm under guidance|RISUG]], a reversible [[male contraceptive]].<ref name='Haine 2010-07-05'> |
Founded in 2005, Parsemus is an advocate of research into the plausibility of [[Reversible inhibition of sperm under guidance|RISUG]] (and a method based on RISUG, called Vasalgel), a reversible [[male contraceptive]].<ref name='Haine 2010-07-05'>{{cite news | first = Rosie | last = Haine | title = Men need more contraceptive choice | date = 2010-07-05 | url = https://www.bbc.co.uk/news/10514490 | work = BBC News | accessdate = 2012-10-13}}</ref><ref name="Sainani 2012">{{cite journal |title=This Time It's a Guy Thing |journal=Stanford Magazine |date= September–October 2012 |last=Sainani |first=Kristin |url=https://alumni.stanford.edu/get/page/magazine/article/?article_id=55985 |accessdate=2017-03-21 }}</ref> The foundation began procuring RISUG's United States [[intellectual property]] rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting [[toxicology testing|toxicology tests]] as an initial step towards [[Food and Drug Administration]] approval.<ref name='Beck 2011-06-14'>{{cite news | first = Melinda | last = Beck | title = 'Honey, It's Your Turn...' | date = 2011-06-14 | url = https://www.wsj.com/articles/SB10001424052702303848104576383730320049892 | work = The Wall Street Journal | accessdate = 2012-10-13}}</ref><ref>{{cite web | url = http://parsemusfoundation.org/Parsemus/New_male_contraceptives.html | title = Parsemus Foundation | accessdate = 2012-10-13 | url-status = dead | archiveurl = https://web.archive.org/web/20121014135626/http://www.parsemusfoundation.org/Parsemus/New_male_contraceptives.html | archivedate = 2012-10-14 }}</ref><ref name="Priceonomics">{{cite news |url=https://priceonomics.com/the-economics-of-male-birth-control/ |title=The Economics of Male Birth Control |work=Priceonomics |date=2015-10-19 |accessdate=2017-03-21 }}</ref> |
||
<ref name='Beck 2011-06-14'> {{cite news | first = Melinda | last = Beck | title = 'Honey, It's Your Turn...' | date = 2011-06-14 | url = https://www.wsj.com/articles/SB10001424052702303848104576383730320049892 | work = The Wall Street Journal | accessdate = 2012-10-13}}</ref><ref> {{cite web | url = http://parsemusfoundation.org/Parsemus/New_male_contraceptives.html | title = Parsemus Foundation | accessdate = 2012-10-13 | url-status = dead | archiveurl = https://web.archive.org/web/20121014135626/http://www.parsemusfoundation.org/Parsemus/New_male_contraceptives.html | archivedate = 2012-10-14 }}</ref><ref name="Priceonomics">{{cite news |url=https://priceonomics.com/the-economics-of-male-birth-control/ |title=The Economics of Male Birth Control |work=Priceonomics |date=2015-10-19 |accessdate=2017-03-21 }}</ref> Animal trials have thus far proved effective with no negative side effects; human trials were being planned for 2015-2016 with missed market release in 2017<ref>{{Cite web |url=http://www.parsemusfoundation.org/vasalgel-faqs/ |title=Archived copy |access-date=2014-09-11 |archive-url=https://web.archive.org/web/20140912003337/http://www.parsemusfoundation.org/vasalgel-faqs/ |archive-date=2014-09-12 |url-status=dead }}</ref> as of 2019. |
|||
Vasalgel production has continually been delayed. Human trials for Vasalgel were approved and planned for 2015–2016 with missed market release in 2017.<ref name="Foundation FAQ">{{Cite web |url=http://www.parsemusfoundation.org/vasalgel-faqs/ |title=Parsemus Foundation » Vasalgel FAQs |access-date=2014-09-11 |archive-url=https://web.archive.org/web/20140912003337/http://www.parsemusfoundation.org/vasalgel-faqs/ |archive-date=2014-09-12 |url-status=dead }}</ref><ref name="Francis">{{Cite book|last=Francis|first=Leslie|title=The Oxford Handbook of Reproductive Ethics|date=2017|publisher=Oxford University Press|isbn=978-0199981878|page=336|url=https://books.google.com/books?id=TS6hDQAAQBAJ&pg=PA336}}</ref> |
|||
| ⚫ | The |
||
| ⚫ | The foundation has also engaged in [[animal testing]] and aims to prioritize [[animal welfare]].<ref name="Foundation FAQ"/> The organization offers resources on alternative methods of fertility control ([[neutering]]) for dogs and cats. Its focus has been on ovary-sparing spay for female dogs and cats, vasectomy for male dogs and cats, and non-surgical sterilization using calcium chloride-based formulations for male dogs and cats.<ref>{{cite web|url=https://www.parsemus.org/|title=Parsemus Foundation|access-date=January 5, 2019}}</ref> As of 2017, reversibility has been unsuccessful in animal trials in the United States.<ref name="Francis"/> |
||
| ⚫ | The foundation was also noted for its support of the ''[[Archives of Internal Medicine]]'''s ''less-is-more'' series.<ref name='ORiordanin 2011-07-15'/><ref name='Brownlee 2011-07-19'> |
||
| ⚫ | The foundation was also noted for its support of the ''[[Archives of Internal Medicine]]'''s ''less-is-more'' series.<ref name='ORiordanin 2011-07-15'/><ref name='Brownlee 2011-07-19'>{{cite news | first = Shannon | last = Brownlee | title = Less Is More | date = 2011-07-19 | url = http://health.newamerica.net/blogposts/2011/less_is_more-55062 | work = New America Foundation | accessdate = 2012-10-13 | url-status = dead | archiveurl = https://web.archive.org/web/20120916035721/http://health.newamerica.net/blogposts/2011/less_is_more-55062 | archivedate = 2012-09-16 }}</ref> |
||
Parsemus Foundation has not managed to bring RISUG to mass use. |
|||
==References== |
==References== |
||
| Line 16: | Line 20: | ||
*[http://parsemusfoundation.org Official site] |
*[http://parsemusfoundation.org Official site] |
||
{{authority control}} |
|||
| ⚫ | |||
[[Category:Medical and health foundations in the United States]] |
[[Category:Medical and health foundations in the United States]] |
||
[[Category:Men's health organizations]] |
[[Category:Men's health organizations]] |
||
| ⚫ | |||
Latest revision as of 03:37, 18 January 2024
 | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. (April 2013) |
The Parsemus Foundation is an American non-governmental organization whose objective is to advance low-cost evidence-based medicines not pursued by the pharmaceutical industry.[1] The foundation's focus is on supporting small proof-of-concept studies and then pursuing press coverage of the results, so that the advances change treatment practice rather than disappearing into the scientific literature. Many of the studies supported involve low-cost approaches that are not under patent.
Background[edit]
Founded in 2005, Parsemus is an advocate of research into the plausibility of RISUG (and a method based on RISUG, called Vasalgel), a reversible male contraceptive.[2][3] The foundation began procuring RISUG's United States intellectual property rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting toxicology tests as an initial step towards Food and Drug Administration approval.[4][5][6]
Vasalgel production has continually been delayed. Human trials for Vasalgel were approved and planned for 2015–2016 with missed market release in 2017.[7][8]
The foundation has also engaged in animal testing and aims to prioritize animal welfare.[7] The organization offers resources on alternative methods of fertility control (neutering) for dogs and cats. Its focus has been on ovary-sparing spay for female dogs and cats, vasectomy for male dogs and cats, and non-surgical sterilization using calcium chloride-based formulations for male dogs and cats.[9] As of 2017, reversibility has been unsuccessful in animal trials in the United States.[8]
The foundation was also noted for its support of the Archives of Internal Medicine's less-is-more series.[1][10]
Parsemus Foundation has not managed to bring RISUG to mass use.
References[edit]
- ^ a b O'Riordan, Michael (2011-07-15). "What Is the Parsemus Foundation?". Heartwire. Medscape. Retrieved 2017-03-21.
- ^ Haine, Rosie (2010-07-05). "Men need more contraceptive choice". BBC News. Retrieved 2012-10-13.
- ^ Sainani, Kristin (September–October 2012). "This Time It's a Guy Thing". Stanford Magazine. Retrieved 2017-03-21.
- ^ Beck, Melinda (2011-06-14). "'Honey, It's Your Turn...'". The Wall Street Journal. Retrieved 2012-10-13.
- ^ "Parsemus Foundation". Archived from the original on 2012-10-14. Retrieved 2012-10-13.
- ^ "The Economics of Male Birth Control". Priceonomics. 2015-10-19. Retrieved 2017-03-21.
- ^ a b "Parsemus Foundation » Vasalgel FAQs". Archived from the original on 2014-09-12. Retrieved 2014-09-11.
- ^ a b Francis, Leslie (2017). The Oxford Handbook of Reproductive Ethics. Oxford University Press. p. 336. ISBN 978-0199981878.
- ^ "Parsemus Foundation". Retrieved January 5, 2019.
- ^ Brownlee, Shannon (2011-07-19). "Less Is More". New America Foundation. Archived from the original on 2012-09-16. Retrieved 2012-10-13.
External links[edit]
 | This article related to a non-profit organization is a stub. You can help Wikipedia by expanding it. |